FDA approves the first HPV self-collection solutions

Int J Gynecol Cancer. 2024 Nov 4;34(11):1833. doi: 10.1136/ijgc-2024-005784.

Esra Bilir^#^{1

2}, Koray Görkem Saçıntı^#^{3

4}, Joanna Kacperczyk-Bartnik⁵, Murat Gultekin⁶

¹ Department of Gynaecology and Obstetrics, University Hospital Schleswig-Holstein - Campus Kiel, Kiel, Germany.
² Department of Global Health, Koc University Graduate School of Health Sciences, Istanbul, Turkey.
³ Department of Obstetrics and Gynecology, Aksaray University Training and Research Hospital, Aksaray, Turkey mail@koraygorkemsacinti.com.
⁴ Department of Public Health, Hacettepe University Faculty of Medicine, Ankara, Turkey.
⁵ II Department of Obstetrics and Gynecology, Medical University of Warsaw, Warszawa, Poland.
⁶ Department of Obstetrics and Gynecology, Hacettepe University Faculty of Medicine, Ankara, Ankara, Turkey.

^# Contributed equally.

No abstract available

Keywords: Cervical Cancer; Gynecology; Pathology; Quality of Life.